05/01/2026
The FDA PreCheck Pilot Program is changing what it means to build a compliant pharmaceutical facility in the U.S.
Launched in February 2026, the program gives new domestic manufacturing facilities early engagement with the FDA — technical advice, pre-operational reviews, and a clearer path through inspection — before a single product ships.
The goal: less regulatory uncertainty, faster routes to market, and a stronger U.S. pharma supply chain.
For facilities entering the program, every element of your hygiene and contamination control infrastructure is going to be scrutinized from day one.
That includes your entry points.
Dry shoe sanitation — automated, consistent, zero liquid introduction — is exactly the kind of control that holds up under that level of scrutiny.
Building a new facility? It's worth getting the fundamentals right from the ground up.
Learn more at: patho3gen.com